Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity (Details Textual)

v2.4.0.8
Transactions Affecting Stockholders' Equity (Details Textual) (USD $)
 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Sep. 30, 2014
Settlement Agreement [Member]
Sep. 30, 2014
Settlement Agreement [Member]
May 28, 2014
2014 Equity Line of Credit [Member]
Nov. 21, 2012
2014 Equity Line of Credit [Member]
Sep. 30, 2014
2014 Equity Line of Credit [Member]
Sep. 30, 2014
Plan 1997 [Member]
Sep. 30, 2013
Plan 2010 [Member]
Sep. 30, 2013
Plan 2010 [Member]
Sep. 30, 2014
Plan 2010 [Member]
Sep. 30, 2014
Directors Plan 2010 [Member]
Sep. 30, 2014
Amended Option Plan 1997 [Member]
Sep. 30, 2013
Common Stock [Member]
Sep. 30, 2014
Common Stock [Member]
Sep. 30, 2014
Common Stock [Member]
Dutchess [Member]
2012 Equity Line of Credit [Member]
Stockholders' Equity [Line Items]                                      
Maximum Number Of Common Stock Authorized For Issuance Over 36 Months                 2,500,000                    
Maximum Amount Entitled To Put To Investor In One Draw Down Notice, Percentage Of Average Daily Volume On Trading Day                 500.00%                    
Maximum Amount Entitled To Put To Investor In One Draw Down Notice                 $ 250,000                    
Investory Right To Use Excess Proceeds, Maximum Percentage                 5.00% 5.00%                  
Share Purchase Put Restrictions Maximum Percentage Of Ownership Held By Investor To Purchase Shares In Equity Line Of Credit                 9.99% 4.99%                  
Stock Issued During Period Shares Under Specific Agreement                                     698,207
Stock Issued During Period Value Specific Agreement                                     1,200,000
Options outstanding - Shares                     67,000                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                           1,600,000 425,000        
Share Based Compensation Arrangement By Share Based Payment Award, Options, Deemed Cancelled                           581,750          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures                       15,000 15,000     4,500,000      
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Common Stock Shares Unissued                     2,500,000                
Equity Method Investment Ownership Percentage Required For Rights Exercisable Under Right Agreement     15.00%                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period                     1,481,750                
Equity Line, Purchase Price Percentage                 95.00% 95.00%                  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                     900,000     267,159 176,135        
Cash Less Exercise Of Right Terms     In the event of a cashless exercise of the Right and the acquirer has acquired less than 50% beneficial ownership of the Company                                
Share Based Compensation Arrangement By Share Based Payment Option Expiration Terms     No incentive stock option could be exercisable more than ten years after the date of grant or five years after the date of grant where the individual owns more than ten percent of the total combined voting power of all classes of stock. Stockholders approved the 1997 Plan in Fiscal 1998.                                
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 45   $ 45                                
Common Stock, Shares, Issued 24,696,786   24,696,786   21,437,059         2,561,520                  
Agreement Term               36 months                      
Purchase Price Value                   500,000                  
Proceeds From Issuance Of Common Stock     4,909,000 195,000           3,700,000                  
Common Stock, Capital Shares Reserved for Future Issuance               3,000,000   438,480                  
Percentage of Discount on Exercise of Right     50.00%                                
Stock Granted During Period Shares Employment Agreement                                 16,470    
Common Stock, Shares, Outstanding           3,896,764 3,896,764                        
Proceeds from Other Equity             440,000                        
Loss Contingency Accrual, Payments             500,000                        
Related Party Costs             37,000                        
Treasury Stock, Shares, Acquired             3,896,764                     3,896,764  
Additional Paid In Capital, Common Stock 53,811,000   53,811,000   43,607,000 5,100,000 5,100,000                        
Common Stock, Par or Stated Value Per Share $ 0.0005   $ 0.0005   $ 0.0005 $ 1.31 $ 1.31                        
General and Administrative Expense, Total 1,917,000 1,306,000 6,228,000 4,521,000   97,000 97,000                        
Accrued Liabilities, Fair Value Disclosure           $ 1,300,000 $ 1,300,000